GlassScriptPhysician profile
Joanna Lee
NPI 1164964342
$2,648.33
in general payments reported to CMS, 2019-2025
34 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $431 · 2022: $681 · 2023: $698 · 2024: $500 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,536.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $449.51 | 2021-2025 | Xtandi, Myrbetriq |
| Olympus America INC. | $182.44 | 2023-2025 | Uretero-Reno Videoscope, Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $162.99 | 2021-2024 | |
| Antares Pharma, INC. | $162.21 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Janssen Biotech, INC. | $149.40 | 2024-2025 | Erleada |
| Astrazeneca Pharmaceuticals LP | $146.35 | 2021-2024 | Lynparza |
| Dendreon Pharmaceuticals LLC | $132.56 | 2022-2024 | Provenge |
| Convatec INC. | $97.49 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $95.84 | 2022-2024 | |
| Accord Healthcare, INC. | $85.34 | 2023-2024 | |
| Boston Scientific Corporation | $79.60 | 2021-2022 | |
| 180 Medical, INC. | $78.50 | 2023-2025 | |
| Blue Earth Diagnostics | $71.44 | 2021-2025 | Posluma |
| Rochester Medical Corporation | $68.88 | 2021-2022 | |
| Axonics, INC. | $62.94 | 2021-2023 | Axonics, Bulkamid |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $54.86 | 2021-2024 | |
| Mission Pharmacal Company | $53.98 | 2021-2023 | Uribel |
| Progenics Pharmaceuticals, INC. | $52.18 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $47.28 | 2022 | |
| Urovant Sciences INC | $47.12 | 2022 | |
| Hollister Incorporated | $45.04 | 2023 | Infyna Chic, Vapro, Onli |
| Tolmar Pharmaceuticals, INC. | $38.46 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $34.48 | 2023 | Seglentis |
| Abbvie INC. | $25.53 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $24.29 | 2025 | |
| Endo USA, INC. | $24.29 | 2025 | Xiaflex |
| Clarus Therapeutics INC. | $24.20 | 2021 | |
| Tolmar, INC. | $23.89 | 2023 | |
| Avation Medical, INC. | $23.38 | 2025 | Vivally System |
| Amgen INC. | $23.20 | 2022 | |
| Pfizer INC. | $22.60 | 2024 | |
| Profound Medical Corp. | $19.97 | 2025 | Tulsa-Pro |
| Halozyme INC | $19.92 | 2023 | |
| Endo Pharmaceuticals INC. | $18.17 | 2023 | Xiaflex, Aveed, Edex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.